NDC Package 51672-1397-9 Tavaborole

Solution Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51672-1397-9
Package Description:
1 BOTTLE, WITH APPLICATOR in 1 CARTON / 10 mL in 1 BOTTLE, WITH APPLICATOR
Product Code:
Proprietary Name:
Tavaborole
Non-Proprietary Name:
Tavaborole
Substance Name:
Tavaborole
Usage Information:
This medication is used to treat toenail infection caused by fungus. It works by stopping the growth of certain types of fungus. Tavaborole belongs to a class of drugs known as oxaborole antifungals. This medication treats only fungal infections. It will not work for other types of infection, such as those caused by bacteria. Unnecessary use or misuse of any drug used to treat infection can lead to its decreased effectiveness.
11-Digit NDC Billing Format:
51672139709
NDC to RxNorm Crosswalk:
  • RxCUI: 1543177 - tavaborole 5 % Topical Solution
  • RxCUI: 1543177 - tavaborole 43.5 MG/ML Topical Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Taro Pharmaceuticals U.s.a., Inc.
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA212215
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    05-07-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51672-1397-9?

    The NDC Packaged Code 51672-1397-9 is assigned to a package of 1 bottle, with applicator in 1 carton / 10 ml in 1 bottle, with applicator of Tavaborole, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. The product's dosage form is solution and is administered via topical form.

    Is NDC 51672-1397 included in the NDC Directory?

    Yes, Tavaborole with product code 51672-1397 is active and included in the NDC Directory. The product was first marketed by Taro Pharmaceuticals U.s.a., Inc. on May 07, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51672-1397-9?

    The 11-digit format is 51672139709. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151672-1397-95-4-251672-1397-09